HIV integrase as a target for antiviral chemotherapy

Reviews in Medical Virology

Volumn 12, Issue 3, 2002, Pages 179-193

  Nair, Vasu ^a,b  

^a E11 SSH   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2,4 DIOXABUTANOIC ACID DERIVATIVE; AMINOACRIDINE; CAFFEIC ACID; CAMPTOTHECIN; CHLOROQUINE; DINUCLEOTIDE; DINUCLEOTIDE INHIBITOR; DOXORUBICIN; ELLIPTICINE; ETHIDIUM BROMIDE; HETEROCYCLIC COMPOUND; INTEGRASE; INTEGRASE INHIBITOR; MITOXANTRONE; NATURAL PRODUCT; NUCLEOTIDE; OLIGONUCLEOTIDE; OLIGONUCLEOTIDE INHIBITOR; PRIMAQUINE; QUERCETIN; QUINOLINE DERIVATIVE; SPERMINE; SULFONE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS ENZYME;

BINDING SITE; DNA SEQUENCE; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; REVIEW;

ANTI-HIV AGENTS; DNA, VIRAL; DRUG DESIGN; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NUCLEOTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS INTEGRATION;

EID: 0036095978     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.350     Document Type: Review

References (63)

1. The retroviral enzymes
2. Multifactorial nature of human immunodeficiency viral disease: Implications for therapy
3. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis
4. Toward improved anti-HIV chemoherapy: Therapeutic strategies for intervention with HIV infections
5. Advances in HIV/AIDS therapy
6. In search of a selective antiviral chemotherapy
7. New developments in anti-HIV chemotherapy
8. New antiretroviral agents: Looking beyond protease and reverse transcriptase
9. HIV-1 integrase: Structural organization, conformational changes, and catalysis
10. HIV integrase structure and function
11. Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases
12. Catalytic domain of HIV-1 integrase: Identification of a soluble mutant by systematic replacement of hydrophobic residues
13. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro
14. Structural implication of spectroscopic characterization of putative zinc finger peptide from HIV-1 integrase
15. Viral long terminal repeat substrate binding characteristics of HIV-1 integrase
16. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity
17. Integrating DNA: Transposases and retroviral integrases
18. Characterization of the minimal DNA-binding domain of the HIV integrase protein
19. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type I integrase
20. Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′-deoxythymidylate
21. Effect of nucleotide analogues on human immunodeficiency virus type 1 integrase
22. Isodideoxynucleosides: A conceptually new class of nucleoside antiviral agents
23. Antiviral activity of isomeric dideoxynucleosides of D- and L-related stereo-chemistry
24. Antiviral, metabolic and pharmacokinetic studies on the isomeric dideoxynucleoside, 4(S)-(6-arnino-9H-purin-9-tetrahydro-2(S)-furanmethanol
25. Inhibition of HIV integrase by novel nucleotides bearing tricyclic bases
26. T30177, An oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type I
27. Triplex-mediated inhibition of HIV DNA integration in vitro
28. Triplex helix formation with short oligonucleotide-intercalator conjugates matching the HIV-1 U3 LTR end sequence
29. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures
30. Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotides
31. Recognition and inhibition of HIV integrase by novel dinucleotides
32. Recognition and inhibition of HIV-1 integrase by a novel dinucleotide
33. Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV integrase
34. Recognition and inhibition of HIV integrase by novel dinucleotides
35. 2′-Deoxyadenylyl-(3′→5′)-isodideoxyadenosine. A unique dinucleotide: Synthesis and characterization
36. Novel oligodeoxyribonucleotides incorporating L-related isodeoxynucleosides: Solid phase synthesis, enzymology, and CD studies
37. Self-complementary oligodeoxyribonucleotides incorporating L-related isodideoxynucleosides: Synthesis, physical characterization enzymology, and CD studies
38. A new method for the phosphorylation of nucleosides
39. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro
40. Phosphorodithioate DNA as a potential therapeutic drug
41. Assay of 2′,5′-oligoadenylate phosphodiesterase activity in mouse L-cell extracts
42. Dinucleoside phosphates containing arabinose or deoxyxylose. Hydrolysis by exonuclease and stacking properties
43. Binding modes of two non-natural dinucleotide inhibitors of HIV integrase
44. Inhibitors of human immunodeficiency virus integrase
45. Potential inhibitors of HIV integrase
46. Inhibition of human immunodeficiency virus integrase by bis-catechols
47. Hydroxylated aromatic inhibitors of HIV-1 integrase
48. A peptide inhibitor of HIV-1 integrase from a combinatorial library
49. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
50. 4-Aryl-2, 4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells
51. Retroviral integrase inhibitors year 2000: Update and perspectives
52. Inhibition of HIV integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds
53. Dicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors
54. Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids
55. Diarylsulfones a novel class of human immunodeficiency virus type 1 ntegrase inhibitors
56. Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture
57. Structure and absolute stereochemistry of HIV-1 integrase inhibitor integric acid. A novel eremophilane sesquiterpenoid produced by a Xylariai sp.
58. HIV integrase, a brief overview from chemistry to therapeutics
59. Incidence and impact of resistance against approved antiretroviral drugs
60. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design
61. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase